S-1 · primary and resale
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
POAS$1.09-0.91%
PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd
Sector: Industrial Instruments For Measurement, Display, and ControlIndustry: Medical - DevicesCountry: SGExchange: NYSE
Mkt Cap:$1.2M
Float & O/S:
Inst Own:
DilutionScan read 14 of PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd's SEC filings and found 1 warrant series, 1 equity line, 2 S-1 registrations and 2 completed offerings on file for POAS. The latest dilution event on file is a registration statement on May 18, 2026. Analysis updated Oct 21, 2026.
Signal8 Summary
POAS
Going-concern warning, cash nearly gone
Snapshot
Phaos is a tiny Singapore microscopy-equipment maker that's nearly out of cash. FY 2024 revenue collapsed 91% to $132K, and the company lost $4.0M against just $102K of cash on hand.
What's Happening Right Now
- : Phaos postponed the shareholder meeting on the reverse split and share authorization votes from August 18 to August 31, 2026, to revise the proposal wording.
- : On Aug 9, 2026 Phaos scheduled a shareholder vote on a reverse split of up to 50:1 to meet NYSE American's $1 minimum price rule, plus a huge increase in authorized shares and a big new stock award to the CEO carrying 20 votes per share.
- : Phaos filed to raise about $5M by selling shares and warrants at roughly $0.22 each; the filing includes a going-concern warning and discloses revenue fell 91% with a S$5.1M net loss for the year ended April 30, 2025.
- : Phaos said it noticed unusual trading in its shares between May 29 and June 1, 2026, but could not identify any undisclosed business reason for it.
Raise routes on file: pending S-1 · latest dilution event 169 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
May 18, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Completed
S-1 · primary offering
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Equity line
Issued 2026
Commitment
Sold to date
Remaining
- Agreement date
- Term ends
- Discount
Public offering
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Public offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your POAS trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
